Study To Examine Safety, Tolerability And Pharmacokinetics Of Intravenous Doses And Oral Dose Of GSK233705

Clinical trial NCT00500461 · COMPLETED

Trial details

NCT number: NCT00500461
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pulmonary Disease, Chronic Obstructive

Start date: 2007-06-04
Primary completion: 2007-07-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.